Zobrazeno 1 - 10
of 2 023
pro vyhledávání: '"Dual therapy"'
Autor:
Wei-Chen Tai, I-Ting Wu, Hsin-Ming Wang, Pao-Yuan Huang, Chih-Chien Yao, Cheng-Kun Wu, Shih-Cheng Yang, Chih-Ming Liang, Pin-I Hsu, Seng-Kee Chuah
Publikováno v:
Journal of Microbiology, Immunology and Infection, Vol 57, Iss 4, Pp 601-608 (2024)
Background: High-dose dual therapy (HDDT) using proton-pump inhibitors (PPI) and amoxicillin attracted attention for its simplicity and lower adverse event profile. Besides, vonoprazan is not available worldwide. This real-world study aims to compare
Externí odkaz:
https://doaj.org/article/1c33ef16ceec47d4b5996f3996b41daf
Autor:
Yanyun Dou, Guangfu Liao, Ruichao Lu, Lingsong Su, Ke Lan, Zhihao Meng, Shanfang Qin, Wei Huang, Yuanlong Xu, Yu Lv, Yuhong Wen, Shuanglai Lan, Yong Zuo, Yong Zhang
Publikováno v:
BMC Infectious Diseases, Vol 24, Iss 1, Pp 1-6 (2024)
Abstract Background Antiretroviral therapy (ART) has transformed HIV management, with various regimens available. Dolutegravir (DTG) plus lamivudine (3TC) dual therapy is now the one of the first line regimens. Methods A retrospective, observational
Externí odkaz:
https://doaj.org/article/7a804aeb80264855ad34c19e82c477d4
Autor:
Chen Chen, Daya Zhang, Shimei Huang, Fan Zeng, Da Li, Xiaodong Zhang, Runxiang Chen, Shiju Chen, Jun Wang, Feihu Bai
Publikováno v:
BMC Gastroenterology, Vol 24, Iss 1, Pp 1-9 (2024)
Abstract Objective To compare the potential efficacy and safety of dual therapy and quadruple therapy with vonoprazan (VPZ) as well as the standard quadruple therapy of proton pump inhibitor (PPI) for the eradication of Helicobacter pylori (Hp) infec
Externí odkaz:
https://doaj.org/article/2d8e2d9c24334d37a9bc1c68094016d5
Autor:
Abraham Saborido-Alconchel, Ana Serna-Gallego, María Trujillo-Rodriguez, Esperanza Muñoz-Muela, Ana I. Álvarez-Ríos, Carmen Lozano, Silvia Llaves-Flores, Nuria Espinosa, Cristina Roca-Oporto, Marta Herrero, Cesar Sotomayor, Alicia Gutierrez-Valencia, Luis F. Lopez-Cortes
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
ObjectiveTo compare the long-term effects on immune parameters, inflammation, and HIV-1 reservoir after switching to a two-drug (2DR) versus maintaining an integrase inhibitor (InSTI)-based three-drug regimen (3DR).MethodsCross-sectional study in whi
Externí odkaz:
https://doaj.org/article/54a9b36fe1f346459b2724ba340f0505
Publikováno v:
Xin yixue, Vol 55, Iss 3, Pp 204-207 (2024)
Objective To evaluate clinical efficacy of the combination of Vonoprazan and high-dose Amoxicillin in the initial eradication treatment of Helicobacter pylori (Hp). Methods Select 200 patients with Hp infection who have not undergone Hp eradicati
Externí odkaz:
https://doaj.org/article/20199126f7784a01a6a7dea32cfd6084
Publikováno v:
International Journal of COPD, Vol Volume 19, Pp 439-450 (2024)
Michael Bogart,1 Gary Yat-Hung Leung,2 Anissa Cyhaniuk,2 Kristi DiRocco3 1Customer Engagement, Value, Evidence and Outcomes (CEVEO) US Medical Affairs, GSK, Research Triangle Park, NC, USA; 2STATinMED Research, Dallas, TX, USA; 3US Medical Affairs, G
Externí odkaz:
https://doaj.org/article/44b702508f63424284d0b259424fb106
Autor:
Requena G, Czira A, Banks V, Wood R, Tritton T, Castillo C, Yeap J, Wild R, Compton C, Rothnie KJ, Herth FJ, Quint JK, Ismaila AS
Publikováno v:
International Journal of COPD, Vol Volume 18, Pp 2039-2054 (2023)
Gema Requena,1 Alexandrosz Czira,1 Victoria Banks,2 Robert Wood,2 Theo Tritton,2 Catherine Castillo,2 Jie Yeap,2 Rosie Wild,2 Chris Compton,1 Kieran J Rothnie,1 Felix JF Herth,3 Jennifer K Quint,4 Afisi S Ismaila5,6 1GSK, R&D Global Medical, Brentfor
Externí odkaz:
https://doaj.org/article/00c5da3c3cc146a1a80d99adcd255022
Autor:
Martin Borlich, Uwe Zeymer, Harm Wienbergen, Hans-Peter Hobbach, Alessandro Cuneo, Raffi Bekeredjian, Oliver Ritter, Birgit Hailer, Klaus Hertting, Marcus Hennersdorf, Werner Scholtz, Peter Lanzer, Harald Mudra, Markus Schwefer, Peter-Lothar Schwimmbeck, Christoph Liebetrau, Holger Thiele, Christoph Claas, Thomas Riemer, Ralf Zahn, Leon Iden, Gert Richardt, Ralph Toelg
Publikováno v:
Cardiology and Therapy, Vol 13, Iss 1, Pp 89-101 (2023)
Abstract Introduction The preference for using transradial access (TRA) over transfemoral access (TFA) in patients requiring percutaneous coronary intervention (PCI) is based on evidence suggesting that TRA is associated with less bleeding and fewer
Externí odkaz:
https://doaj.org/article/f9664d75a011444aa006c451e76fe60d
Publikováno v:
Beni-Suef University Journal of Basic and Applied Sciences, Vol 12, Iss 1, Pp 1-8 (2023)
Abstract Background Diabetes is one of the world’s most widespread conditions, and diabetic patients are among the most likely to engage in fierce battles with this chronic disease. Which group should be added-on as a dual therapy for Egyptian pati
Externí odkaz:
https://doaj.org/article/5b84925121824d77b57be90c5e4fd2c2
Autor:
T. O. Okorokova, O. N. Kryuchkova
Publikováno v:
Кубанский научный медицинский вестник, Vol 30, Iss 5, Pp 54-63 (2023)
Background. Initial dual antihypertensive therapy is currently considered as the first management step for the majority of patients with arterial hypertension. However, it often fails to achieve the target blood pressure levels. An approved algorithm
Externí odkaz:
https://doaj.org/article/9b256f45949c48278550fc35b08afc93